Table 2.

Antitumor responses according to FATSI staining

Best Response	All (n = 41)	FATSI + (n = 29)	FATSI Neg. (n = 10)	(ND/In, n = 2) c
CR	2	0	2	0
PR	5	2	3	0
SD	11	9	2	0
PD	21	17	3	1
NE	2	1	–	1
iORR	18%	7%	50%	0%
MiPFSa (range)	47 (26-NR)b days	43 (26-NR) days	202 (41-NR) days	39 (38–40) days
20 Weeks PFS	32%	21%	70%	0%

^aMiPFS Median progression free survival, ^bNR Not reached, ^cND/In Not done/insufficient, NE Non-evaluable